COLONIC N-ACETYLATION OF 5-AMINOSALICYLIC ACID IN INFLAMMATORY BOWEL-DISEASE

被引：81
|
作者：
ALLGAYER, H
AHNFELT, NO
KRUIS, W
KLOTZ, U
FRANKHOLMBERG, K
SODERBERG, HNA
PAUMGARTNER, G
机构：
[1] DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL,STUTTGART,FED REP GER
[2] UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT MED 2,D-8000 MUNICH 70,FED REP GER
[3] PHARMACIA AB,UPPSALA,SWEDEN
来源：
GASTROENTEROLOGY | 1989年 / 97卷 / 01期
关键词：
D O I：
10.1016/0016-5085(89)91412-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：38 / 41
页数：4
相关论文
共 50 条
  • [41] Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease -: A systematic review
    Gisbert, JP
    Gomollón, F
    Maté, J
    Pajares, JM
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (03) : 471 - 488
  • [42] Impact of concomitant 5-aminosalicylic acid therapy on vedolizumab efficacy and safety in Inflammatory Bowel Disease
    Ungaro, R.
    Kadali, H.
    Zhang, W.
    Adsul, S.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S321 - S321
  • [43] 5-aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
    Terdiman, Jonathan P.
    Steinbuch, Michael
    Blumentals, William A.
    Ullman, Thomas A.
    Rubin, David T.
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (04) : 367 - 371
  • [44] Synthesis, characterization and evaluation of derivates of 5-aminosalicylic acid with antioxidant activity in inflammatory bowel disease
    Ramirez Duran, Leticia Araceli
    Trujillo Ferrara, Jose Guadalupe
    Cecilia Rosales-Hernandez, Martha
    Ramirez Rosales, Daniel
    Correa Basurto, Jose
    FASEB JOURNAL, 2010, 24
  • [45] Lupus-like syndrome caused by 5-aminosalicylic acid in patients with inflammatory bowel disease
    Kirkpatrick, AW
    Bookman, AA
    Habal, F
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1999, 13 (02): : 159 - 162
  • [46] Impact of 5-Aminosalicylic Acid on Ustekinumab in Inflammatory Bowel Disease: A Retrospective Medical Claims Analysis
    Nishida, Yu
    Hosomi, Shuhei
    Fujimoto, Koji
    Kobayashi, Yumie
    Nakata, Rieko
    Maruyama, Hirotsugu
    Ominami, Masaki
    Nadatani, Yuji
    Fukunaga, Shusei
    Otani, Koji
    Tanaka, Fumio
    Fujiwara, Yasuhiro
    INFLAMMATORY BOWEL DISEASES, 2025,
  • [47] A NEW SLOW-RELEASE FORM OF 5-AMINOSALICYLIC ACID FOR THE ORAL TREATMENT OF INFLAMMATORY BOWEL-DISEASE - BIOPHARMACEUTIC AND CLINICAL PHARMACOKINETIC CHARACTERISTICS
    KLOTZ, U
    MAIER, KE
    FISCHER, C
    BAUER, KH
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1985, 35-1 (03): : 636 - 639
  • [48] Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid
    Wiwattanapatapee, R
    Lomlim, L
    Saramunee, K
    JOURNAL OF CONTROLLED RELEASE, 2003, 88 (01) : 1 - 9
  • [49] 5-AMINOSALICYLIC ACID, A COFACTOR FOR COLONIC PROSTACYCLIN SYNTHESIS
    HOULT, JRS
    PAGE, H
    LANCET, 1981, 2 (8240): : 255 - 255
  • [50] REVIEW: Role of 5-Aminosalicylic Acid (5-ASA) in Treatment of Inflammatory Bowel Disease: A Systemic Review
    Javier P. Gisbert
    Fernando Gomollón
    José Maté
    José María Pajares
    Digestive Diseases and Sciences, 2002, 47 : 471 - 488
12345